{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:38:06Z","timestamp":1768401486550,"version":"3.49.0"},"reference-count":67,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,11,14]]},"abstract":"<jats:p>Deletions of chromosome 20q are frequent abnormalities in myelodysplastic syndrome (MDS) and myeloproliferative neoplasms. Stoner et al identify STK4, which encodes Hippo kinase MST1, as the candidate gene from the deleted region that, when deleted, promotes features of MDS and induces myelofibrosis in the presence of JAK2V617F through modulation of inflammatory pathways.<\/jats:p>","DOI":"10.1182\/blood.2019000170","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T01:25:20Z","timestamp":1566437120000},"page":"1730-1744","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation"],"prefix":"10.1182","volume":"134","author":[{"given":"Samuel A.","family":"Stoner","sequence":"first","affiliation":[{"name":"Moores Cancer Center,"},{"name":"Biomedical Sciences Graduate Program,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yan","sequence":"additional","affiliation":[{"name":"Moores Cancer Center,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine Tin Heng","family":"Liu","sequence":"additional","affiliation":[{"name":"Moores Cancer Center,"},{"name":"Division of Biological Sciences,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei-Ichiro","family":"Arimoto","sequence":"additional","affiliation":[{"name":"Moores Cancer Center,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Shima","sequence":"additional","affiliation":[{"name":"Moores Cancer Center,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-You","family":"Wang","sequence":"additional","affiliation":[{"name":"Moores Cancer Center,"},{"name":"Department of Pathology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4669-037X","authenticated-orcid":false,"given":"Daniel T.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Moores Cancer Center,"},{"name":"Division of Biological Sciences,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5603-4598","authenticated-orcid":false,"given":"Rafael","family":"Bejar","sequence":"additional","affiliation":[{"name":"Moores Cancer Center,"},{"name":"Biomedical Sciences Graduate Program,"},{"name":"Division of Hematology and Oncology, Department of Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona","family":"Jamieson","sequence":"additional","affiliation":[{"name":"Moores Cancer Center,"},{"name":"Biomedical Sciences Graduate Program,"},{"name":"Division of Regenerative Medicine, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Liang","family":"Guan","sequence":"additional","affiliation":[{"name":"Moores Cancer Center,"},{"name":"Biomedical Sciences Graduate Program,"},{"name":"Department of Pharmacology, University of California San Diego, La Jolla, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Er","family":"Zhang","sequence":"additional","affiliation":[{"name":"Moores Cancer Center,"},{"name":"Biomedical Sciences Graduate Program,"},{"name":"Division of Biological Sciences,"},{"name":"Department of Pathology,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2019,8,21]]},"reference":[{"issue":"7","key":"2019111521554814100_B1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMra0803109","article-title":"Chromosomal abnormalities in cancer","volume":"359","author":"Fr\u00f6hling","year":"2008","journal-title":"N Engl J Med"},{"issue":"7176","key":"2019111521554814100_B2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature06494","article-title":"Identification of RPS14 as a 5q- syndrome gene by RNA interference screen","volume":"451","author":"Ebert","year":"2008","journal-title":"Nature"},{"issue":"1","key":"2019111521554814100_B3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nm.2054","article-title":"Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype","volume":"16","author":"Starczynowski","year":"2010","journal-title":"Nat Med"},{"issue":"6","key":"2019111521554814100_B4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1182\/blood-2012-04-426965","article-title":"CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia","volume":"121","author":"McNerney","year":"2013","journal-title":"Blood"},{"issue":"7","key":"2019111521554814100_B5","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/s41375-018-0029-9","article-title":"A decade of progress in myelodysplastic syndrome with chromosome 5q deletion","volume":"32","author":"List","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"2019111521554814100_B6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ccr.2013.05.006","article-title":"Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome","volume":"24","author":"Rhyasen","year":"2013","journal-title":"Cancer Cell"},{"issue":"4","key":"2019111521554814100_B7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ccr.2014.08.001","article-title":"Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS","volume":"26","author":"Schneider","year":"2014","journal-title":"Cancer Cell"},{"issue":"2","key":"2019111521554814100_B8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2141.1996.d01-1896.x","article-title":"Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders","volume":"95","author":"Asimakopoulos","year":"1996","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111521554814100_B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2004.02.002","article-title":"Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders","volume":"19","author":"Kralovics","year":"2005","journal-title":"Blood Rev"},{"issue":"12","key":"2019111521554814100_B10","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00277-009-0745-3","article-title":"Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS\/MPN category","volume":"88","author":"Bacher","year":"2009","journal-title":"Ann Hematol"},{"issue":"5","key":"2019111521554814100_B11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1200\/JCO.2010.31.1175","article-title":"Unraveling the molecular pathophysiology of myelodysplastic syndromes","volume":"29","author":"Bejar","year":"2011","journal-title":"J Clin Oncol"},{"key":"2019111521554814100_B12","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1038\/bcj.2016.5","article-title":"Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia","volume":"6","author":"Patnaik","year":"2016","journal-title":"Blood Cancer J"},{"issue":"5","key":"2019111521554814100_B13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0609.2009.01224.x","article-title":"Conventional cytogenetics in myelofibrosis: literature review and discussion","volume":"82","author":"Hussein","year":"2009","journal-title":"Eur J Haematol"},{"issue":"34","key":"2019111521554814100_B14","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1038\/sj.onc.1203728","article-title":"Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC\/BAC contig and identification of candidate genes","volume":"19","author":"Bench","year":"2000","journal-title":"Oncogene"},{"issue":"7","key":"2019111521554814100_B15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00277-008-0462-3","article-title":"Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions","volume":"87","author":"Douet-Guilbert","year":"2008","journal-title":"Ann Hematol"},{"issue":"6","key":"2019111521554814100_B16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bjh.12710","article-title":"Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact","volume":"164","author":"Bacher","year":"2014","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111521554814100_B17","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1172\/JCI66113","article-title":"Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions","volume":"123","author":"Aziz","year":"2013","journal-title":"J Clin Invest"},{"issue":"15","key":"2019111521554814100_B18","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1182\/blood-2010-02-270611","article-title":"Depletion of L3MBTL1 promotes the erythroid differentiation of human hematopoietic progenitor cells: possible role in 20q- polycythemia vera","volume":"116","author":"Perna","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111521554814100_B19","doi-asserted-by":"crossref","first-page":"e00825","DOI":"10.7554\/eLife.00825","article-title":"MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy","volume":"2","author":"Heinrichs","year":"2013","journal-title":"eLife"},{"issue":"3","key":"2019111521554814100_B20","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/leu.2012.241","article-title":"MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia","volume":"27","author":"Clarke","year":"2013","journal-title":"Leukemia"},{"issue":"5","key":"2019111521554814100_B21","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/leu.2017.31","article-title":"Deletion of Ptpn1 induces myeloproliferative neoplasm","volume":"31","author":"Jobe","year":"2017","journal-title":"Leukemia"},{"issue":"4","key":"2019111521554814100_B22","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer","volume":"163","author":"Yu","year":"2015","journal-title":"Cell"},{"issue":"6","key":"2019111521554814100_B23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nm.3562","article-title":"Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers","volume":"20","author":"Cottini","year":"2014","journal-title":"Nat Med"},{"issue":"2","key":"2019111521554814100_B24","doi-asserted-by":"crossref","first-page":"e32013","DOI":"10.1371\/journal.pone.0032013","article-title":"Normal hematopoietic stem cell function in mice with enforced expression of the Hippo signaling effector YAP1","volume":"7","author":"Jansson","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"2019111521554814100_B25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.it.2018.05.003","article-title":"Noncanonical Hippo Signalling in the Regulation of Leukocyte Function","volume":"39","author":"Kurz","year":"2018","journal-title":"Trends Immunol"},{"issue":"9","key":"2019111521554814100_B26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/ni1374","article-title":"Spatiotemporal regulation of the kinase Mst1 by binding protein RAPL is critical for lymphocyte polarity and adhesion","volume":"7","author":"Katagiri","year":"2006","journal-title":"Nat Immunol"},{"issue":"51","key":"2019111521554814100_B27","doi-asserted-by":"crossref","first-page":"20321","DOI":"10.1073\/pnas.0810773105","article-title":"The Nore1B\/Mst1 complex restrains antigen receptor-induced proliferation of na\u00efve T cells","volume":"105","author":"Zhou","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111521554814100_B28","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ncomms2105","article-title":"Mst1 regulates integrin-dependent thymocyte trafficking and antigen recognition in the thymus","volume":"3","author":"Ueda","year":"2012","journal-title":"Nat Commun"},{"issue":"4","key":"2019111521554814100_B29","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.20111692","article-title":"The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes","volume":"209","author":"Mou","year":"2012","journal-title":"J Exp Med"},{"issue":"11","key":"2019111521554814100_B30","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1172\/JCI87043","article-title":"MST1-dependent vesicle trafficking regulates neutrophil transmigration through the vascular basement membrane","volume":"126","author":"Kurz","year":"2016","journal-title":"J Clin Invest"},{"issue":"11","key":"2019111521554814100_B31","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3268","article-title":"Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity","volume":"16","author":"Geng","year":"2015","journal-title":"Nat Immunol"},{"key":"2019111521554814100_B32","doi-asserted-by":"crossref","first-page":"14275","DOI":"10.1038\/ncomms14275","article-title":"Dendritic cell MST1 inhibits Th17 differentiation","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun"},{"issue":"7708","key":"2019111521554814100_B33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-018-0177-0","article-title":"Hippo\/Mst signalling couples metabolic state and immune function of CD8\u03b1+ dendritic cells","volume":"558","author":"Du","year":"2018","journal-title":"Nature"},{"issue":"15","key":"2019111521554814100_B34","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1182\/blood-2011-09-378364","article-title":"MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival","volume":"119","author":"Nehme","year":"2012","journal-title":"Blood"},{"issue":"15","key":"2019111521554814100_B35","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood-2011-09-378158","article-title":"The phenotype of human STK4 deficiency","volume":"119","author":"Abdollahpour","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2019111521554814100_B36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.clim.2015.06.010","article-title":"STK4 (MST1) deficiency in two siblings with autoimmune cytopenias: A novel mutation","volume":"161","author":"Halacli","year":"2015","journal-title":"Clin Immunol"},{"key":"2019111521554814100_B37","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1038\/ncomms6901","article-title":"Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes","volume":"6","author":"Gerstung","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"2019111521554814100_B38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0609.2011.01618.x","article-title":"Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis","volume":"87","author":"Skov","year":"2011","journal-title":"Eur J Haematol"},{"issue":"22","key":"2019111521554814100_B39","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1182\/blood-2014-02-554634","article-title":"Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis","volume":"123","author":"Rampal","year":"2014","journal-title":"Blood"},{"key":"2019111521554814100_B40","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1038\/ncomms9357","article-title":"MAP4K family kinases act in parallel to MST1\/2 to activate LATS1\/2 in the Hippo pathway","volume":"6","author":"Meng","year":"2015","journal-title":"Nat Commun"},{"issue":"5","key":"2019111521554814100_B41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.molcel.2016.10.034","article-title":"Characterization of Hippo Pathway Components by Gene Inactivation","volume":"64","author":"Plouffe","year":"2016","journal-title":"Mol Cell"},{"issue":"2","key":"2019111521554814100_B42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2141.2007.06776.x","article-title":"Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation","volume":"139","author":"Gupta","year":"2007","journal-title":"Br J Haematol"},{"issue":"7","key":"2019111521554814100_B43","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.leukres.2011.02.008","article-title":"Characteristics and outcome of myelodysplastic syndromes (MDS) with isolated 20q deletion: a report on 62 cases","volume":"35","author":"Braun","year":"2011","journal-title":"Leuk Res"},{"issue":"6","key":"2019111521554814100_B44","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/bloodadvances.2016003129","article-title":"Mosaic chromosome 20q deletions are more frequent in the aging population","volume":"1","author":"Machiela","year":"2017","journal-title":"Blood Adv"},{"issue":"7714","key":"2019111521554814100_B45","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41586-018-0321-x","article-title":"Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations","volume":"559","author":"Loh","year":"2018","journal-title":"Nature"},{"issue":"5","key":"2019111521554814100_B46","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ajcp\/aqw222","article-title":"Comparison of the Mutational Profiles of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocytosis","volume":"147","author":"Song","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2019111521554814100_B47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjh.13260","article-title":"A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients","volume":"169","author":"Wassie","year":"2015","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111521554814100_B48","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1242\/dmm.006817","article-title":"Mouse models of myeloproliferative neoplasms: JAK of all grades","volume":"4","author":"Li","year":"2011","journal-title":"Dis Model Mech"},{"key":"2019111521554814100_B49","doi-asserted-by":"crossref","first-page":"670580","DOI":"10.1155\/2015\/670580","article-title":"Circulating Cytokine Levels as Markers of Inflammation in Philadelphia Negative Myeloproliferative Neoplasms: Diagnostic and Prognostic Interest","volume":"2015","author":"Mondet","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"3","key":"2019111521554814100_B50","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/2159-8290.CD-14-0736","article-title":"JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response","volume":"5","author":"Kleppe","year":"2015","journal-title":"Cancer Discov"},{"issue":"1","key":"2019111521554814100_B51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ccell.2017.11.009","article-title":"Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms [published corrections appears in Cancer Cell. 2018;33(4):785-787]","volume":"33","author":"Kleppe","year":"2018","journal-title":"Cancer Cell"},{"issue":"suppl 1","key":"2019111521554814100_B52","doi-asserted-by":"crossref","first-page":"69.17","DOI":"10.4049\/jimmunol.192.Supp.69.17","article-title":"Development of non-overlapping multiplex antibody arrays for the quantitative measurement of 400 human and 200 mouse proteins in parallel","volume":"192","author":"Mao","year":"2014","journal-title":"J Immunol"},{"issue":"11","key":"2019111521554814100_B53","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1172\/JCI81203","article-title":"STK4 regulates TLR pathways and protects against chronic inflammation-related hepatocellular carcinoma","volume":"125","author":"Li","year":"2015","journal-title":"J Clin Invest"},{"issue":"10","key":"2019111521554814100_B54","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111521554814100_B55","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ni.3654","article-title":"Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasia [published correction appears in Nat Immunol. 2017;18;474]","volume":"18","author":"Fang","year":"2017","journal-title":"Nat Immunol"},{"issue":"11","key":"2019111521554814100_B56","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1084\/jem.20141898","article-title":"Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling","volume":"212","author":"Varney","year":"2015","journal-title":"J Exp Med"},{"issue":"8","key":"2019111521554814100_B57","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ncb0805-758","article-title":"Ubiquitin signalling in the NF-kappaB pathway","volume":"7","author":"Chen","year":"2005","journal-title":"Nat Cell Biol"},{"issue":"11","key":"2019111521554814100_B58","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1038\/s41375-018-0112-2","article-title":"Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes","volume":"32","author":"Hosseini","year":"2018","journal-title":"Leukemia"},{"issue":"15","key":"2019111521554814100_B59","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1182\/blood-2018-03-784116","article-title":"Chronic immune response dysregulation in MDS pathogenesis","volume":"132","author":"Barreyro","year":"2018","journal-title":"Blood"},{"issue":"10","key":"2019111521554814100_B60","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2018-10-844654","article-title":"The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes","volume":"133","author":"Sallman","year":"2019","journal-title":"Blood"},{"issue":"21","key":"2019111521554814100_B61","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1200\/JCO.2011.34.8540","article-title":"Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes","volume":"29","author":"Kristinsson","year":"2011","journal-title":"J Clin Oncol"},{"issue":"11","key":"2019111521554814100_B62","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1172\/JCI67580","article-title":"Induction of myelodysplasia by myeloid-derived suppressor cells","volume":"123","author":"Chen","year":"2013","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111521554814100_B63","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2018.07.003","article-title":"Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations","volume":"34","author":"Lee","year":"2018","journal-title":"Cancer Cell"},{"issue":"25","key":"2019111521554814100_B64","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2016-07-730556","article-title":"The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype","volume":"128","author":"Basiorka","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2019111521554814100_B65","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"issue":"12","key":"2019111521554814100_B66","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/ajh.25230","article-title":"Primary myelofibrosis: 2019 update on diagnosis, risk-stratification and management","volume":"93","author":"Tefferi","year":"2018","journal-title":"Am J Hematol"},{"issue":"19","key":"2019111521554814100_B67","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1182\/blood-2018-02-834820","article-title":"The identification of fibrosis-driving myofibroblast precursors reveals new therapeutic avenues in myelofibrosis","volume":"131","author":"Kramann","year":"2018","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/20\/1730\/1506115\/bloodbld2019000170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/20\/1730\/1506115\/bloodbld2019000170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T10:10:53Z","timestamp":1695118253000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/134\/20\/1730\/374960\/Hippo-kinase-loss-contributes-to-del20q"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,21]]},"references-count":67,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2019,8,21]]},"published-print":{"date-parts":[[2019,11,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019000170","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,21]]}}}